• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对从静脉注射免疫球蛋白产品、阿尔茨海默病患者血浆和认知正常个体中分离出的tau反应性抗体的表征。

Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals.

作者信息

Krestova Michala, Hromadkova Lenka, Bilkova Zuzana, Bartos Ales, Ricny Jan

机构信息

National Institute of Mental Health, Klecany, Czech Republic; Third Faculty of Medicine, Charles University, Prague, Czech Republic.

National Institute of Mental Health, Klecany, Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic; Department of Biological and Biochemical Sciences, University of Pardubice, Pardubice, Czech Republic.

出版信息

J Neuroimmunol. 2017 Dec 15;313:16-24. doi: 10.1016/j.jneuroim.2017.09.011. Epub 2017 Oct 6.

DOI:10.1016/j.jneuroim.2017.09.011
PMID:29153604
Abstract

The presence of natural tau-reactive antibodies was reported in human blood. In this study, we isolated and characterized natural tau-reactive antibodies occurring in IVIG product Flebogamma, plasma of patients with Alzheimer's disease (AD) and older cognitively normal persons (controls). Using blotting immunoassays and ELISA, we showed reactivity of antibodies obtained from IVIG and controls against a recombinant fragment of tau (155-421aa) and aggregates present in brains of AD patients. In contrast, antibodies isolated from plasma of AD patients reacted mainly with the recombinant full-length tau form and tau monomeric forms in brain tissue.

摘要

据报道,人体血液中存在天然的tau反应性抗体。在本研究中,我们分离并鉴定了静脉注射免疫球蛋白产品Flebogamma、阿尔茨海默病(AD)患者血浆和认知正常的老年人(对照组)血浆中存在的天然tau反应性抗体。通过印迹免疫分析和酶联免疫吸附测定,我们发现从静脉注射免疫球蛋白和对照组获得的抗体对tau重组片段(155 - 421aa)以及AD患者大脑中存在的聚集体具有反应性。相比之下,从AD患者血浆中分离出的抗体主要与脑组织中的重组全长tau形式和tau单体形式发生反应。

相似文献

1
Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals.对从静脉注射免疫球蛋白产品、阿尔茨海默病患者血浆和认知正常个体中分离出的tau反应性抗体的表征。
J Neuroimmunol. 2017 Dec 15;313:16-24. doi: 10.1016/j.jneuroim.2017.09.011. Epub 2017 Oct 6.
2
Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product.静脉注射免疫球蛋白产品中抗tau蛋白天然抗体的鉴定与表征
J Neuroimmunol. 2015 Dec 15;289:121-9. doi: 10.1016/j.jneuroim.2015.10.017. Epub 2015 Oct 28.
3
ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin products.酶联免疫吸附试验测定静脉注射用免疫球蛋白制品中磷酸化 tau 的特异性抗体。
Int Immunopharmacol. 2015 Oct;28(2):1108-12. doi: 10.1016/j.intimp.2015.08.022. Epub 2015 Aug 30.
4
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein.静脉注射用免疫球蛋白产品含有针对重组人 tau 蛋白的特异性抗体。
Int Immunopharmacol. 2013 Aug;16(4):424-8. doi: 10.1016/j.intimp.2013.04.034. Epub 2013 May 10.
5
Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer's Disease.阿尔茨海默病患者血清中 Tau 蛋白和神经丝重链抗体水平降低。
J Alzheimers Dis. 2018;64(3):751-760. doi: 10.3233/JAD-180039.
6
Specific binding of intravenous immunoglobulin products to tau peptide fragments.静脉注射免疫球蛋白产品与tau肽片段的特异性结合。
Int Immunopharmacol. 2014 Aug;21(2):279-82. doi: 10.1016/j.intimp.2014.05.009. Epub 2014 May 21.
7
Changes in concentrations of tau-reactive antibodies are dependent on sex in Alzheimer's disease patients.阿尔茨海默病患者tau 反应性抗体浓度的变化与性别有关。
J Neuroimmunol. 2018 Sep 15;322:1-8. doi: 10.1016/j.jneuroim.2018.05.004. Epub 2018 May 19.
8
Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants.选择性识别人阿尔茨海默病脑源性 tau 变体的抗体片段的分离和特性分析。
Neurobiol Aging. 2020 Oct;94:7-14. doi: 10.1016/j.neurobiolaging.2020.04.014. Epub 2020 Apr 24.
9
Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects.在阿尔茨海默病患者和健康受试者中检测针对未磷酸化tau蛋白及其与神经原纤维缠结相关的磷酸化状态的循环抗体。
Neurosci Lett. 2006 Dec 20;410(2):90-3. doi: 10.1016/j.neulet.2006.01.072.
10
Isolation and characterization of antibody fragments selective for toxic oligomeric tau.对有毒寡聚体tau具有选择性的抗体片段的分离与鉴定
Neurobiol Aging. 2015 Mar;36(3):1342-55. doi: 10.1016/j.neurobiolaging.2014.12.002. Epub 2014 Dec 11.

引用本文的文献

1
Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis.特定自身抗体在神经退行性疾病中的作用:致病抗体还是有前景的诊断生物标志物?
Antibodies (Basel). 2023 Dec 8;12(4):81. doi: 10.3390/antib12040081.
2
Efficacy and safety of blood derivatives therapy in Alzheimer's disease: a systematic review and meta-analysis.血液衍生物疗法治疗阿尔茨海默病的疗效和安全性:系统评价和荟萃分析。
Syst Rev. 2022 Nov 29;11(1):256. doi: 10.1186/s13643-022-02115-y.
3
Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases.
针对神经原蛋白的自身抗体可作为神经退行性疾病的生物标志物。
Theranostics. 2022 Mar 28;12(7):3045-3056. doi: 10.7150/thno.72126. eCollection 2022.
4
Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer's Disease.tau 反应性内源性抗体:起源、功能及其对阿尔茨海默病病理生理学的影响。
J Immunol Res. 2019 Aug 6;2019:7406810. doi: 10.1155/2019/7406810. eCollection 2019.
5
An Overview on the Clinical Development of Tau-Based Therapeutics.基于 Tau 的治疗药物的临床开发概述。
Int J Mol Sci. 2018 Apr 11;19(4):1160. doi: 10.3390/ijms19041160.